hR3 modification with DOTA-NHS. 90Y labeling and biodistribution
The conjugation, characterization and biodistribution of -DOTA-hR3 radioimmunoconjugate are reported in this work. DOTA was used as bifunctional chelating agent. Molar ratios 320:1, 160:1 and 88:1 DOTA/monoclonal antibody hR3 were studied in order to evaluate their influence on the integrity of conj...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA)
2011-01-01
|
| Series: | Nucleus |
| Subjects: | |
| Online Access: | http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/547 |